More FDA Transitions: CDRH Deputy Director Out, New Chief of Staff And General Counsel In

The US FDA is seeing more staff turnover this week, with CDRH deputy director for science Douglas Kelly announcing his departure while the agency gets a new chief counsel and chief of staff.

Staff Turnover - Concept
(Andrii Yalanskyi/Shutterstock)

More from Medtech Insight

More from Policy & Regulation